APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adult and Adolescent Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Adult and Adolescent Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025187 pages

Choose your research edition.

Industry ResearchAdult and Adolescent Vaccines Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Adult and Adolescent Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Adult and Adolescent Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adult and Adolescent Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Adult and Adolescent Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adult and Adolescent Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adult and Adolescent Vaccines include Novartis, Merck, Pfizer, GlaxoSmithKline and Sanofi Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Adult and Adolescent Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adult and Adolescent Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adult and Adolescent Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adult and Adolescent Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Adult and Adolescent Vaccines Segment by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

Sanofi Aventis

Adult and Adolescent Vaccines Segment by Type

Seasonal Vaccines

Travel Vaccines

Adult and Adolescent Vaccines Segment by Application

Adult

Adolescent

Adult and Adolescent Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Adolescent Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adult and Adolescent Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Adolescent Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Adult and Adolescent Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adult and Adolescent Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Adult and Adolescent Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Adult and Adolescent Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Adult and Adolescent Vaccines Industry Trends Table 2. Adult and Adolescent Vaccines Industry Drivers Table 3. Adult and Adolescent Vaccines Industry Opportunities and Challenges Table 4. Adult and Adolescent Vaccines Industry Restraints Table 5. Global Adult and Adolescent Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Adult and Adolescent Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Adult and Adolescent Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Adult and Adolescent Vaccines Sales Market Share by Manufacturers Table 9. Global Adult and Adolescent Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Adult and Adolescent Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Adult and Adolescent Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Adult and Adolescent Vaccines Manufacturers, Product Type & Application Table 13. Global Adult and Adolescent Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Adult and Adolescent Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Seasonal Vaccines Table 17. Major Manufacturers of Travel Vaccines Table 18. Global Adult and Adolescent Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 20. Global Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 21. Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Adult and Adolescent Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Adult and Adolescent Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (k units) Table 25. Global Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (k units) Table 26. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Adolescent Table 30. Global Adult and Adolescent Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 32. Global Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 33. Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Adult and Adolescent Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Adult and Adolescent Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (k units) Table 37. Global Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (k units) Table 38. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Adult and Adolescent Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Adult and Adolescent Vaccines Sales by Region (2021-2026) & (k units) Table 42. Global Adult and Adolescent Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Adult and Adolescent Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Adult and Adolescent Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 47. North America Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 48. Europe Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 50. Europe Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 57. Global Adult and Adolescent Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Adult and Adolescent Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Adult and Adolescent Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2027-2032) Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Adult and Adolescent Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Novartis Adult and Adolescent Vaccines Product Portfolio Table 66. Novartis Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Adult and Adolescent Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Adult and Adolescent Vaccines Product Portfolio Table 71. Merck Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Adult and Adolescent Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Adult and Adolescent Vaccines Product Portfolio Table 76. Pfizer Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Adult and Adolescent Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Sanofi Aventis Company Information Table 83. Sanofi Aventis Business Overview Table 84. Sanofi Aventis Adult and Adolescent Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio Table 86. Sanofi Aventis Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Adult and Adolescent Vaccines Distributors List Table 90. Adult and Adolescent Vaccines Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Adult and Adolescent Vaccines Product Image Figure 2. Global Adult and Adolescent Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adult and Adolescent Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Adult and Adolescent Vaccines Sales (2021-2032) & (k units) Figure 5. Global Adult and Adolescent Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Adult and Adolescent Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Seasonal Vaccines Image Figure 9. Travel Vaccines Image Figure 10. Global Adult and Adolescent Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Adult and Adolescent Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Adult and Adolescent Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Adult and Adolescent Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Adolescent Image Figure 18. Global Adult and Adolescent Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Adult and Adolescent Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Adult and Adolescent Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Adult and Adolescent Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Adult and Adolescent Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Adult and Adolescent Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Adult and Adolescent Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Adult and Adolescent Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Adult and Adolescent Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Adult and Adolescent Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Adult and Adolescent Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Adult and Adolescent Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Seasonal Vaccines
  • Travel Vaccines
Applications
  • Adult
  • Adolescent
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Sanofi Aventis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Adult and Adolescent Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Adult and Adolescent Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Adult and Adolescent Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Adult and Adolescent Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Adult and Adolescent Vaccines Market Dynamics
  1. 2.1 Adult and Adolescent Vaccines Industry Trends
  2. 2.2 Adult and Adolescent Vaccines Industry Drivers
  3. 2.3 Adult and Adolescent Vaccines Industry Opportunities and Challenges
  4. 2.4 Adult and Adolescent Vaccines Industry Restraints
3 Adult and Adolescent Vaccines Market by Manufacturers
  1. 3.1 Global Adult and Adolescent Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Adult and Adolescent Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Adult and Adolescent Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Adult and Adolescent Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adult and Adolescent Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Adult and Adolescent Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Adult and Adolescent Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adult and Adolescent Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adult and Adolescent Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adult and Adolescent Vaccines Tier 1, Tier 2, and Tier 3
4 Adult and Adolescent Vaccines Market by Type
  1. 4.1 Adult and Adolescent Vaccines Type Introduction
  2. 4.1.1 Seasonal Vaccines
  3. 4.1.2 Travel Vaccines
  4. 4.2 Global Adult and Adolescent Vaccines Sales by Type
  5. 4.2.1 Global Adult and Adolescent Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Adult and Adolescent Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Adult and Adolescent Vaccines Revenue by Type
  9. 4.3.1 Global Adult and Adolescent Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2032)
5 Adult and Adolescent Vaccines Market by Application
  1. 5.1 Adult and Adolescent Vaccines Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Adolescent
  4. 5.2 Global Adult and Adolescent Vaccines Sales by Application
  5. 5.2.1 Global Adult and Adolescent Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Adult and Adolescent Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Adult and Adolescent Vaccines Revenue by Application
  9. 5.3.1 Global Adult and Adolescent Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2032)
6 Global Adult and Adolescent Vaccines Sales by Region
  1. 6.1 Global Adult and Adolescent Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adult and Adolescent Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Adult and Adolescent Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Adult and Adolescent Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Adult and Adolescent Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Adult and Adolescent Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Adult and Adolescent Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Adult and Adolescent Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Adult and Adolescent Vaccines Revenue by Region
  1. 7.1 Global Adult and Adolescent Vaccines Revenue by Region
  2. 7.1.1 Global Adult and Adolescent Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Adult and Adolescent Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Adult and Adolescent Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Adult and Adolescent Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Adult and Adolescent Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Adult and Adolescent Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Adult and Adolescent Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Adult and Adolescent Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Adult and Adolescent Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Adult and Adolescent Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Adult and Adolescent Vaccines Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Adult and Adolescent Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Adult and Adolescent Vaccines Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Adult and Adolescent Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Adult and Adolescent Vaccines Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Adult and Adolescent Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Adult and Adolescent Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Adult and Adolescent Vaccines Value Chain Analysis
  2. 9.1.1 Adult and Adolescent Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Adult and Adolescent Vaccines Production Mode & Process
  6. 9.2 Adult and Adolescent Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Adult and Adolescent Vaccines Distributors
  9. 9.2.3 Adult and Adolescent Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst